Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JTH1800361	富马酸阿利吉仑	aliskiren hemifumarate	Active ingredient	Chemical Drugs	Disposable Import Drug Application	2018-10-16	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2018-11-06	view
JXHL0800109	ASA404注射用浓溶液	vadimezan	Injection	Chemical Drugs	Import Drug Application	2008-04-21	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-06-09	view
JXHL0800294	ASA404注射用浓溶液	vadimezan	Injection	Chemical Drugs	Import Drug Application	2008-09-09	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-06-25	view
JXHL0800295	ASA404注射用浓溶液	vadimezan	Injection	Chemical Drugs	Import Drug Application	2008-09-09	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-06-25	view
JXHL0800296	AMN107	nilotinib	Active ingredient	Chemical Drugs	Import Drug Application	2008-09-09	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-08-13	view
JXHL0800392	PKC412	midostaurin	Active ingredient	Chemical Drugs	Import Drug Application	2008-12-12	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2010-03-08	view
JXHL0900105	LCQ908片剂	pradigastat	Tablet	Chemical Drugs	Import Drug Application	2009-04-07	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2010-01-15	view
JXHL0900106	LCQ908片剂	pradigastat	Tablet	Chemical Drugs	Import Drug Application	2009-04-03	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2010-01-15	view
JXHL0900107	LCQ908片剂	pradigastat	Tablet	Chemical Drugs	Import Drug Application	2009-04-03	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2010-01-15	view
JXHL0900114	QAB149	indacaterol	Active ingredient	Chemical Drugs	Import Drug Application	2009-04-14	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-12-28	view
JXHL0900115	QAB149	indacaterol	Active ingredient	Chemical Drugs	Import Drug Application	2009-04-09	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2009-12-28	view
JXHL0900379	格隆溴铵	glycopyrronium bromide	Active ingredient	Chemical Drugs	Import Drug Application	2009-11-30	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2010-12-30	view
JXHL0900380	QVA149	glycopyrronium bromide;indacaterol maleate	Active ingredient	Chemical Drugs	Import Drug Application	2009-11-30	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2010-12-30	view
JXHL1000014	SBR759	SBR759	Other	Chemical Drugs	Import Drug Application	2010-01-26	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2010-11-08	view
JXHL1000015	SBR759	SBR759	Other	Chemical Drugs	Import Drug Application	2010-01-19	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2010-11-08	view
JXHL1000016	SBR759	SBR759	Other	Chemical Drugs	Import Drug Application	2010-01-19	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2010-11-08	view
JXHL1100078	BKM120	buparlisib	Active ingredient	Chemical Drugs	Import Drug Application	2011-04-13	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2011-12-22	view
JXHL1100079	BKM120	buparlisib	Active ingredient	Chemical Drugs	Import Drug Application	2011-04-07	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2011-12-22	view
JXHL1100143	BKM120	buparlisib	Active ingredient	Chemical Drugs	Import Drug Application	2011-05-09	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2011-12-22	view
JXHL1100144	BKM120	buparlisib	Active ingredient	Chemical Drugs	Import Drug Application	2011-05-11	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2011-12-22	view